Sp386
THERAPEUTIC DRUG MONITORING IN IBD: DO WE NEED FOR ALL BIOLOGICS AND HOW TO INTERPET RESULTS
Date
May 19, 2024
Presenter
BIDMC
Tracks
Related Products
PREVALENCE AND CHARACTERISTICS OF AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTISITE STUDY
Background: Patients with inflammatory bowel disease (IBD) often modify their diet in attempt to manage their disease and symptoms. In some cases, dietary changes involve excessive restriction, which may place patients at risk for adverse consequences…
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
Recent Advances in IBD Monitoring
This session will examine state of the art technological advances including wearable devices, intestinal ultrasound, and artificial intelligence based endoscopic assessment for determination of IBD activity…
